TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis

Cristina Valacca1, Evelyne Tassone1, Paolo Mignatti2

  • 1Department of Cardiothoracic Surgery, New York University School of Medicine, New York, New York, United States of America.

Plos One
|September 3, 2015
PubMed

Insights

Tissue inhibitor of metalloproteinases-2 (TIMP-2) binding to membrane-type 1 matrix metalloproteinase (MT1-MMP) activates AKT and ERK1/2 pathways. This interaction influences tumor cell apoptosis based on the extracellular environment and stimulus.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a transmembrane proteinase involved in extracellular matrix degradation and intracellular signaling.
  • Previous studies demonstrated that tissue inhibitor of metalloproteinases-2 (TIMP-2) binding to MT1-MMP activates the Ras-ERK1/2 pathway, influencing cell proliferation, migration, and tumor growth.
  • The precise mechanisms by which MT1-MMP and TIMP-2 interaction modulates intracellular signaling and cell fate remain incompletely understood.

Purpose of the Study:

  • To investigate the role of TIMP-2 binding to MT1-MMP in activating AKT signaling.
  • To elucidate the mechanisms underlying TIMP-2-mediated activation of AKT and ERK1/2 pathways.
  • To determine how TIMP-2/MT1-MMP interactions affect tumor cell apoptosis in response to different stimuli and extracellular environments.

Main Methods:

  • Cell culture experiments using MT1-MMP expressing cells.
  • Western blotting to assess the activation of signaling pathways (ERK1/2, AKT).
  • Analysis of apoptosis induction under various conditions (serum starvation, 3D collagen).
  • Investigating the role of Fibroblast growth factor receptor-1 (FGFR1) and Ras in signal transduction.

Main Results:

  • TIMP-2 binding to MT1-MMP induces rapid and sustained AKT activation, independent of MT1-MMP's proteolytic activity.
  • Fibroblast growth factor receptor-1 mediates TIMP-2 induction of ERK1/2 but not AKT activation.
  • Ras activation is crucial for transducing TIMP-2-mediated signals to both ERK1/2 and AKT pathways.
  • TIMP-2/MT1-MMP interaction protects tumor cells from serum starvation-induced apoptosis but promotes apoptosis induced by 3D type I collagen in epithelial cancer cells.

Conclusions:

  • TIMP-2 binding to MT1-MMP activates both AKT and ERK1/2 signaling pathways through a Ras-dependent mechanism.
  • The proteolytic activity of MT1-MMP is not required for TIMP-2-induced AKT activation.
  • The functional outcome of TIMP-2/MT1-MMP interaction on tumor cell apoptosis is context-dependent, offering either pro- or anti-apoptotic signaling based on the extracellular milieu and specific apoptotic trigger.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K